SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Targeted therapy for Alzheimer's treatment. If Anavex 2-73

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
georgejjl Member Profile
 
Followed By 71
Posts 8,659
Boards Moderated 0
Alias Born 04/08/04
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/19/2017 6:47:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/18/2017 9:47:41 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/16/2017 11:07:52 AM
Anavex Life Sciences Reports PK and PD Data from Phase 2a Trial of ANAVEX®2-73 in Mild-to-Moderate Alzheimer’s Disease Pat... "GlobeNewswire Inc." - 10/12/2017 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/6/2017 5:18:01 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/5/2017 5:57:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/2/2017 7:53:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/29/2017 2:33:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/26/2017 3:10:51 PM
Anavex Life Sciences to Present at the Ladenburg Thalmann 2017 Healthcare Conference "GlobeNewswire Inc." - 9/21/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/20/2017 4:51:51 PM
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2017 1:59:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/14/2017 2:28:25 PM
Alzheimer’s Disease: Cannabis Formulation Shows Promise "NetworkNewsWire" - 9/12/2017 8:45:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/8/2017 7:21:13 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 9/7/2017 3:17:45 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 2:22:14 PM
Anavex Life Sciences Issued New U.S. Patent for Composition of Matter Covering ANAVEX™ 2-73 "GlobeNewswire Inc." - 9/5/2017 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/31/2017 2:46:59 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/29/2017 11:13:56 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/25/2017 2:20:18 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/21/2017 11:43:39 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/18/2017 4:55:37 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/14/2017 5:15:55 PM
georgejjl   Thursday, 10/12/17 09:37:13 PM
Re: None
Post # of 125645 
Targeted therapy for Alzheimer's treatment. If Anavex 2-73 can be successful in just 20% of the 5 million Alzheimer's patients in the USA, then that is possibly over a million patients and their families that will benefit.

Quote:


- Systemic analysis using KEM® identifies actionable parameters enabling a precision medicine approach to include best responders in follow-up Phase 2/3 study

§ Additional data to be incorporated

- DNA, RNA and gut microbiota
- Advanced data analytics will enable “targeted therapy” design for new trial



http://www.anavex.com/my_uploads/ANAVEX2-73-PKPD-Phase-2a-2017.pdf

Good luck and GOD bless,

George


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist